文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

中心静脉-动脉血二氧化碳分压差对脓毒性休克患者液体反应性的预测价值:一项前瞻性临床研究

[Predictive value of central venous-to-arterial carbon dioxide partial pressure difference for fluid responsiveness in septic shock patients: a prospective clinical study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2018-01-01
一句话结论脓毒性休克患者基线Pcv-aCO2≤6 mmHg时Pcv-aCO2及其变化不能预测液体反应性,而基线Pcv-aCO2>6 mmHg者基线Pcv-aCO2与ΔPcv-aCO2具有预测价值。

该前瞻性观察研究纳入2015年10月至2017年6月北京协和医院内科ICU收治的40例脓毒性休克患者,均在存在有创血流动力学监测时接受快速补液试验。以补液后心脏指数(CI)增加大于10%定义为有液体反应性。结果显示,基线Pcv-aCO2及ΔPcv-aCO2在全部40例中不能区分有反应者与无反应者(AUC分别为0.50和0.51);但在基线Pcv-aCO2>6 mmHg的16例患者中,基线Pcv-aCO2与ΔPcv-aCO2预测液体反应性的AUC分别为0.85和0.84,切点值分别为8.0 mmHg和-4.2 mmHg时阳性预测值均为1。作者结论认为,基线Pcv-aCO2≤6 mmHg时Pcv-aCO2及其变化不能作为心输出量变化的替代指标来判定补液反应,而基线Pcv-aCO2>6 mmHg者则呈现预测价值。

要点

  • 全部40例脓毒性休克患者中,基线Pcv-aCO2与ΔPcv-aCO2均不能区分补液有反应者与无反应者,AUC分别为0.50(95%CI 0.32-0.69)和0.51(95%CI 0.33-0.70)。
  • 基线Pcv-aCO2>6 mmHg的16例患者中,基线Pcv-aCO2与ΔPcv-aCO2预测液体反应性的AUC分别为0.85(95%CI 0.66-1.00)和0.84(95%CI 0.63-1.00)。
  • 基线Pcv-aCO2>6 mmHg组中,基线Pcv-aCO2切点8.0 mmHg、ΔPcv-aCO2切点-4.2 mmHg时阳性预测值均为1。
  • 基线Pcv-aCO2≤6 mmHg的24例患者中,基线Pcv-aCO2与ΔPcv-aCO2对液体反应性无预测价值。
  • 基线Pcv-aCO2>6 mmHg组补液后Pcv-aCO2显著下降,ΔPcv-aCO2为-3.8±3.4 mmHg,而基线Pcv-aCO2≤6 mmHg组为0.9±2.9 mmHg(P<0.01)。

适用人群与场景

  • 2015年10月至2017年6月北京协和医院内科ICU收治的脓毒性休克患者40例,均在存在有创血流动力学监测时接受快速补液试验。

诊断标准与关键阈值

  • 液体反应性定义为补液试验后心脏指数(CI)增加大于10%;无液体反应性定义为CI无增加或增加小于10%。
  • 按基线Pcv-aCO2初始值将患者分为两组,依据既往研究选择6 mmHg为切点值。

研究设计与关键结果

  • 前瞻性观察研究,最终纳入40例脓毒性休克患者,22例对补液有反应(有反应者),18例无反应(无反应者)。
  • 两组基线生理变量无显著差异;补液后在有反应者中CI和血压显著升高、心率显著下降,Pcv-aCO2无变化;在无反应者中血压显著升高,CI、心率、Pcv-aCO2无变化。
  • 有反应者与无反应者Pcv-aCO2相当;40例中补液前CI与Pcv-aCO2呈负相关(r=-0.391,P=0.012),补液后相关性减弱(r=-0.301,P=0.059);补液后CI变化与Pcv-aCO2变化无显著相关(r=-0.164,P=0.312)。
  • 全部40例中基线Pcv-aCO2和ΔPcv-aCO2不能区分有反应者与无反应者,AUC分别为0.50(95%CI 0.32-0.69)和0.51(95%CI 0.33-0.70);补液前心率、血压及其补液后变化区分能力很差。
  • 补液前16例Pcv-aCO2>6 mmHg者平均CI显著低于24例Pcv-aCO2≤6 mmHg者[CI(mL×s-1×m-2):48.3±11.7 vs. 65.0±18.3,P<0.01],Pcv-aCO2显著高于后者(mmHg:8.4±1.9 vs. 2.9±2.8,P<0.01)。
  • 基线Pcv-aCO2>6 mmHg组补液后Pcv-aCO2显著下降,ΔPcv-aCO2与基线Pcv-aCO2≤6 mmHg组有显著差异(mmHg:-3.8±3.4 vs. 0.9±2.9,P<0.01)。
  • 基线Pcv-aCO2>6 mmHg组中68.8%(11/16)对补液有反应,基线Pcv-aCO2与ΔPcv-aCO2预测液体反应性的AUC分别为0.85(95%CI 0.66-1.00)和0.84(95%CI 0.63-1.00),切点值分别为8.0 mmHg和-4.2 mmHg时阳性预测值均为1。
  • 基线Pcv-aCO2≤6 mmHg组中45.8%(11/24)对补液有反应,基线Pcv-aCO2与ΔPcv-aCO2对液体反应性无预测价值。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究;临床试验注册号NCT01941472。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,基线Pcv-aCO2≤6 mmHg的脓毒性休克患者中,Pcv-aCO2及其变化不能作为心输出量变化的替代指标来判定补液反应。
  • 作者结论认为,基线Pcv-aCO2>6 mmHg的患者中,基线Pcv-aCO2与Pcv-aCO2变化呈现预测价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the accuracy of central venous-to-arterial carbon dioxide partial pressure difference (Pcv-aCO2) before and after rapid rehydration test (fluid challenge) in predicting the fluid responsiveness in patients with septic shock.

METHODS: A prospective observation was conducted. Forty septic shock patients admitted to medical intensive care unit (ICU) of Peking Union Medical College Hospital from October 2015 to June 2017 were enrolled. All of the patients received fluid challenge in the presence of invasive hemodynamic monitoring. Heart rate (HR), blood pressure, cardiac index (CI), Pcv-aCO2 and other physiological variables were recorded at 10 minutes before and immediately after fluid challenge. Fluid responsiveness was defined as an increase in CI greater than 10% after fluid challenge, whereas fluid non-responsiveness was defined as no increase or increase in CI less than 10%. The correlation between Pcv-aCO2 and CI was explored by Pearson correlation analysis. Receiver operating characteristic (ROC) curves were established to evaluate the discriminatory abilities of baseline and the changes after fluid challenge in Pcv-aCO2 and other physiological variables to define the fluid responsiveness. The patients were separated into two groups according to the initial value of Pcv-aCO2. The cut-off value of 6 mmHg (1 mmHg = 0.133 kPa) was chosen according to previous studies. The discriminatory abilities of baseline and the change in Pcv-aCO2 (ΔPcv-aCO2) were assessed in each group.

RESULTS: A total of 40 patients were finally included in this study. Twenty-two patients responded to the fluid challenge (responders). Eighteen patients were fluid non-responders. There was no significant difference in baseline physiological variable between the two groups. Fluid challenge could increase CI and blood pressure significantly, decrease HR notably and had no effect on Pcv-aCO2 in fluid responders. In non-responders, blood pressure was increased significantly and CI, HR, Pcv-aCO2 showed no change after fluid challenge. Pcv-aCO2 was comparable in responders and non-responders. In 40 patients, CI and Pcv-aCO2 was inversely correlated before fluid challenge (r = -0.391, P = 0.012) and the correlation between them weakened after fluid challenge (r = -0.301, P = 0.059). There was no significant correlation between the changes in CI and Pcv-aCO2 after fluid challenge (r = -0.164, P = 0.312). The baseline Pcv-aCO2 and ΔPcv-aCO2 could not discriminate between responders and non-responders, with the area under ROC curve (AUC) of 0.50 [95% confidence interval (95%CI) = 0.32-0.69] and 0.51 (95%CI = 0.33-0.70), respectively. HR and blood pressure before fluid challenge and their changes after fluid challenge showed very poor discriminative performances. Before fluid challenge, 16 patients had a Pcv-aCO2 > 6 mmHg. Their mean CI was significantly lower and Pcv-aCO2 was significantly higher than that in 24 patients whose Pcv-aCO2 ≤ 6 mmHg [n = 24; CI (mL×s-1×m-2): 48.3±11.7 vs. 65.0±18.3, P < 0.01; Pcv-aCO2 (mmHg): 8.4±1.9 vs. 2.9±2.8, P < 0.01]. Pcv-aCO2 was decreased significantly after fluid challenge in patients with an initial Pcv-aCO2 > 6 mmHg and their ΔPcv-aCO2 was notably different as compared with the patients whose baseline Pcv-aCO2 ≤ 6 mmHg (mmHg: -3.8±3.4 vs. 0.9±2.9, P < 0.01). 68.8% (11/16) patients responded to the fluid challenge in patients with an initial Pcv-aCO2 > 6 mmHg. The AUC of the baseline Pcv-aCO2 and ΔPcv-aCO2 to define fluid responsiveness was 0.85 (95%CI = 0.66-1.00) and 0.84 (95%CI = 0.63-1.00), respectively, and the positive predictive value was 1 when the cut-off value was 8.0 mmHg and -4.2 mmHg, respectively. 45.8% (11/24) patients responded to the fluid challenge in patients whose baseline Pcv-aCO2 ≤ 6 mmHg. There was no predictive value of baseline Pcv-aCO2 and ΔPcv-aCO2 on fluid responsiveness.

CONCLUSIONS: Pcv-aCO2 and its change cannot serve as a surrogate of the change in cardiac output to define the response to fluid challenge in septic shock patients whose baseline Pcv-aCO2 ≤ 6 mmHg, while the predictive values of baseline Pcv-aCO2 and the change in Pcv-aCO2 are presented in patients with the initial value of Pcv-aCO2 > 6 mmHg.

CLINICAL TRIAL REGISTRATION: Clinical Trials, NCT01941472.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Liu G, Huang H, Qin H, et al. [Predictive value of central venous-to-arterial carbon dioxide partial pressure difference for fluid responsiveness in septic shock patients: a prospective clinical study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29764550. doi:10.3760/cma.j.issn.2095-4352.2018.05.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。